Search research articles
Contact Us
Filters
Showing results (111-120 of 207) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Erica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Cell Reports
|
January 26, 2017
Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth
Peng Ru, Peng Hu, Feng Geng, et al.
Carcinogenesis
|
June 1, 2014
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Carcinogenesis
|
April 30, 2019
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Cell Reports
|
January 25, 2026
SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicity
Yaogang Zhong, Logan Mazik, Huali Su, et al.
Cell Reports
|
August 2, 2016
Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth
Peng Ru, Peng Hu, Feng Geng, et al.
British Journal of Haematology
|
April 8, 2011
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway
Li-Yuan Bai, Yihui Ma, Samuel K Kulp, et al.
Leukemia & Lymphoma
|
November 19, 2020
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
Soun Khountham, Polina Shindiapina, Xiaokui Mo, et al.
Cell Metabolism
|
June 20, 2020
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress
Xiang Cheng, Feng Geng, Meixia Pan, et al.
Leukemia Research
|
May 31, 2022
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia
Swagata Goswami, Chi-Ling Chiang, Kevan Zapolnik, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 207) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Erica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Cell Reports
|
January 26, 2017
Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth
Peng Ru, Peng Hu, Feng Geng, et al.
Carcinogenesis
|
June 1, 2014
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Carcinogenesis
|
April 30, 2019
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Cell Reports
|
January 25, 2026
SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicity
Yaogang Zhong, Logan Mazik, Huali Su, et al.
Cell Reports
|
August 2, 2016
Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth
Peng Ru, Peng Hu, Feng Geng, et al.
British Journal of Haematology
|
April 8, 2011
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway
Li-Yuan Bai, Yihui Ma, Samuel K Kulp, et al.
Leukemia & Lymphoma
|
November 19, 2020
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
Soun Khountham, Polina Shindiapina, Xiaokui Mo, et al.
Cell Metabolism
|
June 20, 2020
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress
Xiang Cheng, Feng Geng, Meixia Pan, et al.
Leukemia Research
|
May 31, 2022
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia
Swagata Goswami, Chi-Ling Chiang, Kevan Zapolnik, et al.
Page
of 21